Neue Alzheimer-Medikamente wecken große Hoffnungen. Doch bei Lecanemab und Donanemab fällt die Nutzen-Schaden-Bilanz kritisch aus.

Inzwischen sind beide Wirkstoffe in Deutschland auf dem Markt. Die Bewertung des tatsächlichen Nutzens und der möglichen Risiken wirft jedoch Fragen auf.

https://bukopharma.de/pharmabrief/pharma-brief-3-2026-preise-fuer-krebsmedikamente-ntds-und-entwicklungshilfe/alzheimer-medikamente-nutzen-fraglich-schaden-vorhanden/

#Alzheimer #Demenz #Arzneimittelrisiken #Lecanemab #Donanemab

‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s

https://fed.brid.gy/r/https://globalnews.ca/news/11828976/health-canada-second-drug-alzheimers/

Sleepy Don: Let's Take An Honest, Deeper Look at Trump’s Cognitive and Physical Decline

Is Donald Trump receiving treatment for early-stage Alzheimer’s disease?

The speculation centers on two datapoints: the now-famous bruise on the back of his right hand, and news that #Trump recently received an MRI.

A viral video by a medical professional suggested that the bruise pattern and the MRI schedule mirror the monthly infusion regimen for #Kisunla (#donanemab), an #Alzheimer’s drug that requires patients to undergo regular brain imaging to monitor for ARIA, a potentially dangerous swelling or bleeding.

https://michaeldsellers.substack.com/p/sleepy-don-lets-take-an-honest-deeper

#donanemab #alzheimer Donanemab: Speranza concreta contro l'Alzheimer da Lilly

https://www.notizie.buzz/articles/2025/11/25/donanemab-speranza-concreta-contro-l-alzheimer-da-lilly.html

🧠 Gehirn fit halten: Steht die Alzheimerforschung an einem Wendepunkt? 🤔
Neue #Medikamente wecken Hoffnung, aber es bleiben viele Fragezeichen. Der individuelle Lebensstil hat einen großen Einfluss auf die Entstehung und Genese der Krankheit. Darüber sprechen Professor Dr. Frank Jessen und Professor Dr. Alfredo Ramírez im aktuellen Unimagazin ▶️ https://uni.koeln/NYVVR

#uniköln #unicologne #uniklinikkoeln #Alzheimerforschung #Alzheimer #Gehirn #Lebensstil #Lecanemab #Donanemab

FDA Approves Label Change for Alzheimer’s Drug

Brain edema risk expected to be less with new donanemab dosing schedule

The real question is whether it works?

https://cnmri.com/2025/07/14/fda-approves-label-change-for-alzheimers-drug/

#alzheimers #dementia #kisunla #donanemab #fda #brainedema

Will this be the death knell for Alzheimer’s monoclonal antibody treatments 🤔

Preprint on #Alzheimers drug deaths ignites dispute among authors

“Infighting among a group of prominent Alzheimer’s disease researchers has led to the withdrawal of a preprint they co-authored, which suggested a new Alzheimer’s drug markedly increases the risk of death. One scientist involved in the work charges the senior author failed to seek the go-ahead from his co-authors before posting an edited version of the article to a preprint server.”

#Lecanemab #Donanemab #Kisunla #amyloid #dementia
https://www.science.org/content/article/preprint-alzheimer-s-drug-deaths-ignites-dispute-among-authors